浙商銀行(02016.HK)擬A、H股均10股配售3股 集資不逾180億人幣
浙商銀行(02016.HK)(601916.SH)公布A、H配股預案,A股、H股均按每10股配售 3股的比例向全體股東配售。若以截至2022年3月底總股本約212.69億股為基數測算,本次可配售股份數量約63.8億股,其中A股可配售股份數量約50.14億股,H股可配售股份數量約13.66億股。
最終配股價格由董事會授權人士在發行前根據市場情況與保薦機構協商確定。本次配股募集資金不超過180億元人民幣。本次配股募集的資金在扣除相關發行費用後,將全部用於補充核心一級資本,提高資本充足率。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.